How One of the Best Tech Stocks to Buy Today Is Tapping into 300% Industry Growth

0 | By Alex Kagin

Every time I walk out of my apartment and walk past the mountain of packages left for residents in my building, I’m reminded of Amazon.com Inc. (NASDAQ: AMZN).

By now, everyone in the United States has heard of it. You see its packages and boxes in the recycling and delivery trucks with the large, unmistakable Amazon logo. It even has its own fleet of planes that you might see at the airport. Not just an e-commerce company, it also has a music service, the top video game streaming service, payments platform, an over-the-top entertainment platform, and one of the largest web services in the United States. This is how you create a trillion-dollar company.

According to Consumer Intelligence Research Partners, it has 112 million members in its Prime loyalty program as of December 2019. That is 34% of the U.S. population, and given that people sign up as families, eMarketer takes it one step further and suggests that 82% of households have a Prime account.

That is one truly amazing statistic.

This One Company Has What Every Pharma Giant Needs – And They Could Double Your Money In Just Three Years

0 | By Michael A. Robinson

Back in mid-March, I wrote a two-part series on the hunt for a COVID-19 vaccine.

You can read the first part of that series here and the second part right here.

At the time, I noted there were roughly a dozen or so companies involved racing to find a way to stop the deadly disease.

And while that sounded like a lot of scientific effort at the time, it turns out my analysis was too conservative.

We now have well over 100 research teams around the world scrambling for a vaccine or a drug that treats the disease.

Of those, at least two dozen hail from biotech or drug firms, many of them publicly traded.

I don’t know about you but I would love to get in on all that action with a great tech-centric firm that has superior earnings and price appreciation ahead.

And that is just what I’m going to reveal today. Doubling its earnings every 18 months, this “Biotech Goldmine” is set to crush the overall market…

Recent Articles